Diabetes 文獻一篇

bjouxz

Diabetes. 2016 Jan;65(1):269-75. doi: 10.2337/db15-0893. Epub 2015 Oct 15.8 V7 j9 E4 `# ?3 d% `$ f6 m' T! r
The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled Trial.5 _: X1 h, m+ w0 Y2 {8 c9 }6 R
Thazhath SS1, Marathe CS1, Wu T1, Chang J1, Khoo J1, Kuo P2, Checklin HL1, Bound MJ1, Rigda RS1, Crouch B3, Jones KL1, Horowitz M1, Rayner CK43 B9 _  \' H8 M7 K5 X7 w

' L/ P( X' w# p, c$ s! ULink: http://diabetes.diabetesjournals.org/content/65/1/269.long - c2 b! v- Z9 }8 o4 a! T& `
9 w; T5 n2 ^: U5 W/ r! \, g! s
Thanks so much!

farui

The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled Trial
! S: Q$ d7 e! S" X